4.4 Article

Clinical Validation of FusionPlex RNA Sequencing and Its Utility in the Diagnosis and Classification of Hematologic Neoplasms

Related references

Note: Only part of the references are listed.
Review Pathology

Updates on eosinophilic disorders

Alexandar Tzankov et al.

Summary: This review discusses the changes and updates in eosinophilic disorders under the International Consensus Classification (ICC), providing updated understanding and guidance for accurate diagnosis and differentiation.

VIRCHOWS ARCHIV (2023)

Article Hematology

The menin-MLL1 interaction is a molecular dependency in NUP98-rearranged AML

Emily B. Heikamp et al.

Summary: Translocations involving the NUP98 gene are associated with poor prognosis in acute myeloid leukemia (AML). In this study, the efficacy of therapeutic blockade of the menin-MLL1 interaction in NUP98-fusion leukemia models was investigated. The results showed that menin-MLL1 inhibition can effectively suppress the growth of NUP98-fusion-driven leukemia cells and promote their differentiation. Furthermore, in vivo experiments using patient-derived xenograft (PDX) models demonstrated that menin-MLL1 inhibition significantly prolongs the survival of mice with NUP98-fusion-driven AML. These findings suggest that menin-MLL1 inhibition could be a promising targeted therapy for patients with NUP98-rearranged leukemias.

BLOOD (2022)

Article Hematology

Deregulation of JAK2 signaling underlies primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma

Armando N. Bastidas Torres et al.

Summary: This study presents a comprehensive genetic characterization of primary cutaneous CD8(+) aggressive epidermotropic cytotoxic T-cell lymphoma (pcAECyTCL) and identifies overactive JAK2 signaling as a central driver of this lymphoma. The findings suggest the potential of JAK2 inhibitors as a therapeutic option for pcAECyTCL patients.

HAEMATOLOGICA (2022)

Article Hematology

t(4;12)(q12;p13) ETV6-rearranged AML without eosinophilia does not involve PDGFRA: relevance for imatinib insensitivity

Sarah B. Mueller et al.

Summary: This study identified non-PDGFRA gene fusions, such as ETV6-SCFD2, using sequencing technology in AML patients, contradicting the previous findings based on FISH analysis. These results highlight the importance of using sequencing-based assays to confirm the presence of targetable gene fusions in genomic regions.

BLOOD ADVANCES (2022)

Article Hematology

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

Daniel A. Arber et al.

Summary: In 2016, the WHO, Society for Hematopathology, and European Association for Haematopathology collaborated to update the classification of myeloid neoplasms and acute leukemias, advancing the field of myeloid neoplasms and acute leukemias.

BLOOD (2022)

Review Oncology

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms

Joseph D. Khoury et al.

Summary: This paper summarizes the new WHO classification scheme for myeloid and histiocytic/dendritic neoplasms, emphasizing the refinement of diagnostic criteria and the importance of actionable biomarkers, while maintaining global applicability.

LEUKEMIA (2022)

Review Oncology

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

Rita Alaggio et al.

Summary: This article provides an overview of the upcoming 5th edition of the World Health Organization classification of lymphoid tumors, highlighting changes from the previous edition such as reorganization of entities, modification of nomenclature, revision of diagnostic criteria, deletion of entities, introduction of new entities, and inclusion of tumor-like lesions.

LEUKEMIA (2022)

Review Pathology

Myeloid/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or FGFR1 or With PCM1-JAK2

Olga Pozdnyakova et al.

Summary: This study summarized cases involving myeloidlymphoid neoplasms with eosinophilia and different gene rearrangements, revealing heterogeneous disease presentations and emphasizing the importance of accurate diagnosis and classification for these rare disorders. With advancements in RNA sequencing, cryptic rearrangements and additional somatic mutations were identified, expanding our understanding of these neoplasms and improving our ability to diagnose genetically defined disorders.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)

Meeting Abstract Hematology

Myeloid/Lymphoid Neoplasm with Eosinophilia and a Novel RUFY1-Pdgfrb Rearrangement

Karly Williams Silva et al.

BLOOD (2021)

Article Multidisciplinary Sciences

The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms

Jason R. Schwartz et al.

Summary: Pediatric therapy-related myeloid neoplasms have specific somatic drivers at the genomic level, unlike adults, with no evidence of pre-existing minor tMN clones associated with TP53 mutations.

NATURE COMMUNICATIONS (2021)

Article Pathology

JAK2 Rearrangements Are a Recurrent Alteration in CD30+ Systemic T-Cell Lymphomas With Anaplastic Morphology

Megan J. Fitzpatrick et al.

Summary: This study identified JAK2 rearrangements in a subset of CD30(+) ALK(-) systemic PTCL with anaplastic morphology, some of which showed CHL-like morphologic features. The presence of JAK2 rearrangements expands current classification and may offer a therapeutic target through JAK2 inhibition.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)

Article Hematology

Lymphoid blast transformation in an MPN with BCR-JAK2 treated with ruxolitinib: putative mechanisms of resistance

Justin Anthony Chen et al.

Summary: The resistance mechanisms to ruxolitinib in a patient with JAK2-driven hematologic malignancies may involve IKZF1 deletion and an activated B-cell receptor-like signaling phenotype.

BLOOD ADVANCES (2021)

Article Genetics & Heredity

Detection of leukemia gene fusions by targeted RNA-sequencing in routine diagnostics

Marie Engvall et al.

BMC MEDICAL GENOMICS (2020)

Review Cell Biology

The RUFYs, a Family of Effector Proteins Involved in Intracellular Trafficking and Cytoskeleton Dynamics

Remy Char et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Article Pathology

Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter study

Guilin Tang et al.

MODERN PATHOLOGY (2019)

Article Oncology

The MLL recombinome of acute leukemias in 2017

C. Meyer et al.

LEUKEMIA (2018)

Article Oncology

Primary Bone Anaplastic Large Cell Lymphoma Masquerading as Ewing Sarcoma: Diagnosis by Anchored Multiplex PCR

Susan Swee-Shan Hue et al.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2018)

Review Hematology

Myeloid neoplasms with eosinophilia

Andreas Reiter et al.

BLOOD (2017)

Article Oncology

Characterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemia

Lisa J. Russell et al.

GENES CHROMOSOMES & CANCER (2017)

Article Oncology

Genomic alterations of the JAK2 and PDL loci occur in a broad spectrum of lymphoid malignancies

Katrien Van Roosbroeck et al.

GENES CHROMOSOMES & CANCER (2016)

Article Pathology

A Multiplexed Amplicon Approach for Detecting Gene Fusions by Next-Generation Sequencing

Carol Beadling et al.

JOURNAL OF MOLECULAR DIAGNOSTICS (2016)

Letter Hematology

Functional analysis of truncated forms of ETV6

Parisa Rasighaemi et al.

BRITISH JOURNAL OF HAEMATOLOGY (2015)

Article Biochemistry & Molecular Biology

Anchored multiplex FOR for targeted next-generation sequencing

Zongli Zheng et al.

NATURE MEDICINE (2014)

Article Oncology

PICALM-MLLT10 acute myeloid leukemia: A French cohort of 18 patients

Cecile Borel et al.

LEUKEMIA RESEARCH (2012)

Review Oncology

ETV6 fusion genes in hematological malignancies: A review

Etienne De Braekeleer et al.

LEUKEMIA RESEARCH (2012)

Article Oncology

Acute leukemia with PICALM-MLLT10 fusion gene: diagnostic and treatment struggle

Natasha M. Savage et al.

CANCER GENETICS AND CYTOGENETICS (2010)

Article Genetics & Heredity

Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia

Charles G. Mullighan et al.

NATURE GENETICS (2009)